CRISPR Therapeutics AG (NASDAQ:CRSP)

147.29
Delayed Data
As of Dec 04
 +6.83 / +4.86%
Today’s Change
32.30
Today|||52-Week Range
151.11
+141.84%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
AssetsCash156.0M315.5M239.8M456.6M
 
 
 
 
 
Short Term Investment Cash155.0M159.6M-75.8M216.9M
 
 
 
 
 
Cash & Short Term Investments156.0M315.5M239.8M456.6M
 
 
 
 
 
 
ReceivablesReceivables339.0K3.2M2.6M88.0K
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsOther Current Assets540.0K1.5M6.0M9.7M
 
 
 
 
 
Current Assets156.8M320.2M248.4M466.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.4M22.0M22.8M25.9M
 
 
 
 
 
Depreciation-72.0K-942.0K-3.9M-7.4M
 
 
 
 
 
Intangible Assets454.0K399.0K344.0K289.0K
 
 
 
 
 
Other Assets555.0K597.0K950.0K958.0K
 
 
 
 
 
Total Assets159.4M345.0M271.3M489.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable0.004.6M1.6M5.1M
 
 
 
 
Accrued Expenses7.7M14.8M6.8M14.7M
 
 
 
 
 
Other Current Liabilities9.3M14.8M7.0M15.0M
 
 
 
 
 
Other Liabilities10.2M22.0M14.5M27.7M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt38.2M0.000.000.00
 
 
Other Liabilities542.0K12.5M12.1M11.3M
 
 
 
 
 
Total Liabilities124.0M112.1M83.5M96.8M
 
 
 
 
 
 
EquityMinority Interest-325.0K-25.0K0.000.00
 
 
 
Preferred Stock64.5M0.000.000.00
 
 
Common Equity-29.1M232.8M187.8M392.2M
 
 
 
 
 
Total Shareholder Equity35.4M232.8M187.8M392.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding39.4M39.7M40.6M51.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.